Treatment Study for Children and Adolescents With Acute Promyelocitic Leukemia
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
This study is open to all patients with a diagnosis of acute promyelocytic leukemia (APL) who
are PCR positive for the PML-RARĪ± transcript or rarer retinoid sensitive subtypes (i.e.
NPM-RAR-alpha, NuMA-RARalpha) and less than 21 years of age (for AIEOP, see appendix A).
Phase:
Phase 3
Details
Lead Sponsor:
Associazione Italiana Ematologia Oncologia Pediatrica